DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "West Nile Virus Infections - Pipeline Review, H1 2017" report to their offering.
West Nile infection is caused by a virus transmitted by mosquitoes. The West Nile virus is a type of virus known as a Flavivirus. Symptoms include a fever, headache, body aches, skin rash, and swollen lymph glands. Risk factors for developing a more severe form of West Nile virus include conditions that weaken the immune system, such as HIV, organ transplants, and recent chemotherapy, age and pregnancy.
Pharmaceutical and Healthcare latest pipeline guide West Nile Virus Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for West Nile Virus Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I, Preclinical and Discovery stages are 3, 8 and 2 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 3 and 3 molecules, respectively.
West Nile Virus Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
- Report Coverage
- West Nile Virus Infections - Overview
- West Nile Virus Infections - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- West Nile Virus Infections - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- West Nile Virus Infections - Companies Involved in Therapeutics Development
- CEL-SCI Corp
- Fab'entech SA
- Hemispherx Biopharma Inc
- Kineta Inc
- Nanotherapeutics Inc
- Plex Pharmaceuticals Inc
For more information about this report visit http://www.researchandmarkets.com/research/fwm8gw/west_nile_virus